Report finds China targeted AstraZeneca in fraud probe over cancer treatment

Report finds China targeted AstraZeneca in fraud probe over cancer treatment

Pharmaceutical giant AstraZeneca, whose China president is under investigation, was previously investigated for medical insurance fraud cases involving cancer medication sales, according to new Chinese media reports. The news comes after the British-Swedish company announced on its official website last week that its China chief Leon Wang was cooperating “with an ongoing investigation”, and its…

Read More
APAC private capital market looks to positive news from China for growth: Preqin

APAC private capital market looks to positive news from China for growth: Preqin

Asia-Pacific’s private capital sector could get support from Chinese government stimulus as well as greater development of other financial markets in the region, according to data provider Preqin. China’s contribution to the region’s market for private capital has tumbled significantly in recent years, but stimulus measures and reforms from Beijing could spark a turnaround, said…

Read More
Why the Chinese Stock Rally Stalled Today

Why the Chinese Stock Rally Stalled Today

The explosive Chinese stock rally over the last month finally lost steam today after a press conference by Chinese officials failed to sustain investor exuberance over previously announced stimulus measures. Shares of the electric carmaker Li Auto (NASDAQ: LI) traded nearly 7.5% lower as of midday, while shares of the search giant and artificial intelligence…

Read More